SECUKINUMAB VS. ADALIMUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS: A COST PER RESPONDER ANALYSIS AT 48 WEEKS FROM A BRAZILIAN PERSPECTIVE

VALUE IN HEALTH(2017)

引用 0|浏览2
暂无评分
关键词
psoriatic arthritis,adalimumab,treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要